Plain-English translation of NCT07474103 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new pre-surgery treatment approach for people with advanced rectal cancer. All participants will receive one week of focused radiation therapy, followed by six cycles of a four-drug combination: , , , and (which is an immunotherapy drug that helps your immune system fight cancer). If the treatment works very well, some patients may avoid immediate surgery and instead be closely monitored over time.
Advanced rectal cancer is challenging to treat and often requires major surgery with lasting side effects. Researchers want to test whether giving this medication along with chemotherapy and radiation before surgery can shrink tumors more effectively, potentially improve survival, and for some patients, avoid or delay the need for surgery altogether.
You likely qualify if…
You likely don't qualify if…
You will receive one week of focused radiation therapy, followed by six 2-week cycles of intravenous chemotherapy and immunotherapy infusions. During this time, you will have regular visits for blood tests, imaging scans, and medical check-ups to monitor how you are tolerating the treatment. After completing the six cycles, your doctors will reassess your cancer with imaging and decide on the next step—either proceeding to surgery or, if your cancer has responded completely, entering a close monitoring program instead of immediate surgery.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
China